SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Reata Pharmaceuticals, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of February 18, 2022 - (RETA)

NEW YORK, Jan. 26, 2022 /PRNewswire/ -- The Gross Law Firm, securities class action litigators, issues the following notice to shareholders of Reata Pharmaceuticals, Inc.

Shareholders who purchased or otherwise acquired Reata securities, and/or sold Reata put options, between November 9, 2020 and December 8, 2021 are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.

CONTACT US HERE:

https://securitiesclasslaw.com/securities/reata-pharmaceuticals-inc-loss-submission-form-2/?id=22515&from=4

ALLEGATIONS: The complaint alleges that during the class period, Defendants issued materially false and/or misleading statements and/or failed to disclose that: (1) the Food and Drug Administration had raised concerns regarding the validity of the clinical study designed to measure the efficacy and safety of bardoxolone for the treatment of chronic kidney disease caused by Alport syndrome; (2) as a result, there was a material risk that Reata's New Drug Application would not be approved; and (3) as a result of the foregoing, defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

DEADLINE FEBRUARY 18, 2022: Shareholders should not delay in registering for this class action. Register your information here: https://securitiesclasslaw.com/securities/reata-pharmaceuticals-inc-loss-submission-form-2/?id=22515&from=4

NEXT STEPS FOR SHAREHOLDERS: Once you register as a shareholder who purchased shares of RETA during the timeframe listed above, you will be enrolled in a portfolio monitoring software to provide you with status updates throughout the lifecycle of the case. There is no cost or obligation to you to participate in this case.

WHY GROSS LAW FIRM? The Gross Law Firm's mission is to protect the rights of all investors who have suffered as the result of deceit, fraud, and illegal business practices. The Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship. Our team puts in the work to get the maximum recovery on behalf of investors. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY, 10018
Email: [e-mail]
Phone: [phone]

View original content:https://www.prnewswire.com/news-releases/shareholder-alert-the-gross-law-firm-notifies-shareholders-of-reata-pharmaceuticals-inc-of-a-class-action-lawsuit-and-a-lead-plaintiff-deadline-of-february-18-2022--reta-301469079.html

SOURCE The Gross Law Firm

Copyright 2022 PR Newswire